News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
157 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17649)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Drug Development
Wave Life Sciences Initiates Clinical Trial for Lead Program in Duchenne Muscular Dystrophy
This clinical trial marks the next stage in the company’s ongoing commitment to address the significant unmet needs of patients diagnosed with this devastating disease and it is the company’s third clinical trial initiated in 2017.
November 6, 2017
·
7 min read
Biotech Bay
Natera Selected for Circulating Tumor DNA Study in Colorectal Cancer
Natera today announced a second research collaboration with Denmark’s Aarhus University utilizing the company’s Signatera technology to evaluate ctDNA as a useful biomarker for detecting minimal residual disease, treatment response, and disease recurrence in colorectal cancer patients.
November 6, 2017
·
5 min read
West to Showcase New Extensions of the SmartDose Drug Delivery Platform at the PDA Universe of Pre-Filled Syringes and Injection Devices
West’s SmartDose drug delivery platform allows patients to self-administer medication in accordance with their prescribed treatment.
November 6, 2017
·
6 min read
Pharmaleads CEO to Present at Bio-Europe 2017
This year’s BIO-Europe conference will take place from 6-8 November at CityCube in Berlin, Germany.
November 6, 2017
·
1 min read
Notice of EGM in Karolinska Development AB
The shareholders of Karolinska Development AB are invited to the Extraordinary General Meeting on Tuesday November 28, 2017 at 16:00 (CET), at Tomtebodavagen 23 A in Solna, Sweden.
November 6, 2017
·
6 min read
Drug Development
Debiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors Including NSCLC
The trial is being conducted under a clinical collaboration agreement announced last year between Debiopharm International SA and the Merck-Pfizer Alliance.
November 6, 2017
·
5 min read
Drug Development
SOTIO Completes Enrollment of Phase III VIABLE Study in Late Stage Prostate Cancer
The VIABLE study is a randomized, double blind, multicenter, parallel-group Phase III study to evaluate the efficacy and safety of DCVAC/PCa as an add-on therapy to first-line standard of care chemotherapy in men with mCRPC.
November 6, 2017
·
3 min read
Business
Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and CSO
Dr. Garces will become a member of the Executive Board of Epigenomics and oversee Operations, Research and Development, Clinical Affairs, Regulatory and Quality.
November 6, 2017
·
3 min read
Drug Development
Advicenne Announces Positive 6-Month Extension Study Data from Pivotal Phase III Study of ADV7103 in Adults and Children Suffering From Distal Renal Tubular Acidosis (dRTA)
The extension study followed the pivotal phase III trial, which showed ADV7103’s ability to restore the main biological defects observed with the disease, meeting primary and secondary endpoints.
November 6, 2017
·
5 min read
Business
Mesa Labs Reports Second Quarter Results
The company reported its results for the second quarter ended September 30, 2017.
November 6, 2017
·
11 min read
Previous
5 of 16
Next